$TGTX News

TG Therapeutics: The Business Is More Attractive Than The Valuation

TGTX Stock Bucks Broader Biotech Selloff As Multiple Sclerosis Therapy Shows Promising Early Results — Here’s What Investors Need To Know

TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026

TG Therapeutics' Initial Data From Its Phase 1 Trial Of Azercabtagene Zapreleucel In Patients With Progressive Multiple Sclerosis Demonstrates 89% Of Evaluable Participants Had Stable Or Improved Disability Scores At Day 90

TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026

TGTX Stock Rises 60% in 6 Months: Here's What You Should Know

TG Therapeutics (NASDAQ:TGTX) Pairs Strong Growth With a High-Quality Breakout Setup

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis

How TG’s MS Data Wave At MSToronto2026 At TG Therapeutics (TGTX) Has Changed Its Investment Story

TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026

TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech

TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup

TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share

TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound

TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry

Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point